NirvaMed is a medical device company that offers a novel treatment for ST-elevation myocardial infarction heart attacks designed to substantially reduce heart muscle death and redefine the standard of care. They focus on the ischemic area of the heart, without body cooling, and no complex anti-shivering medication management.